Top compounds associated with response to CDC73


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.057 0.1
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.1
mRNA niclosamide CTRPv2 pan-cancer AAC 0.057 0.1
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.052 0.1
mRNA BX-795 GDSC1000 pan-cancer AAC -0.053 0.1
mRNA fingolimod CTRPv2 pan-cancer AAC 0.057 0.1
mRNA Erlotinib CCLE pan-cancer AAC -0.072 0.1
mRNA DBeQ CTRPv2 pan-cancer AAC 0.058 0.1
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.059 0.1
Download CSV